Beyond the Oncogene Revolution: Four New Ways to Combat Cancer-Reference-Cited by-同舟云学术

Beyond the Oncogene Revolution: Four New Ways to Combat Cancer

Published:2016 Issue: Volume:81 Page:85-92
ISSN:0091-7451
Container-title:Cold Spring Harbor Symposia on Quantitative Biology
language:en
Short-container-title:Cold Spring Harb Symp Quant Biol

Author:

Berger Thorsten,Saunders Mary E.,Mak Tak W.

Publisher

Cold Spring Harbor Laboratory

Subject

Genetics,Molecular Biology,Biochemistry

Reference54 articles.

1. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

2. Apple S . 2016. At the Vatican, a search for cancer's miracle cure. The New Yorker. www.newyorker.com/tech/elements/at-the-vatican-a-search-for-cancers-miracle-cure.

3. Abstract CT066: First-in-human phase I trial of the oral PLK4 inhibitor CFI-400945 in patients with advanced solid tumors;Cancer Res,2016

4. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

5. Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond BCG: the approaching era of personalised bladder-sparing therapies for non-muscle-invasive urothelial cancers;Future Oncology;2019-02

2. Epigenetic-Transcriptional Regulation of Fatty Acid Metabolism and Its Alterations in Leukaemia;Frontiers in Genetics;2018-09-24

3. Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine;Genes & Diseases;2018-09

4. The oxidoreductase p66Shc acts as tumor suppressor in BRAFV 600E‐transformed cells;Molecular Oncology;2018-05-05

5. Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma;Oncotarget;2017-11-24